These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

688 related items for PubMed ID: 27825291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW, Qu Z, Qin AC, Pan H, Ye J, Jiang Y.
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [Abstract] [Full Text] [Related]

  • 4. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D, Baraban E, Lisby A, Jalali-Farahani S, Zhang P, Livolsi V.
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [Abstract] [Full Text] [Related]

  • 5. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
    Shi CL, Guo Y, Lyu YC, Nanding ZABYS, Gao WC, Shi TF, Qin HD, Liu SY.
    Zhonghua Zhong Liu Za Zhi; 2017 May 23; 39(5):361-366. PubMed ID: 28535653
    [Abstract] [Full Text] [Related]

  • 6. PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.
    Li R, Li M, Sun B, Qi M, Peng C, Li H, Zheng S, Liu Q, Jiang C.
    In Vivo; 2023 May 23; 37(6):2820-2828. PubMed ID: 37905619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N, Zhang L, Wu WL, Ji QH, Lu ZW, Zhu YX, Lin DZ.
    Tumour Biol; 2016 Jul 23; 37(7):8783-9. PubMed ID: 26743781
    [Abstract] [Full Text] [Related]

  • 9. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
    Shin JH, Ha TK, Park HK, Ahn MS, Kim KH, Bae KB, Kim TH, Choi CS, Kim TK, Bae SK, Kim SH.
    Int J Surg; 2013 Jul 23; 11(9):944-7. PubMed ID: 23820062
    [Abstract] [Full Text] [Related]

  • 10. The clinicopathologic differences of central lymph node metastasis in predicting lateral lymph node metastasis and prognosis in papillary thyroid cancer associated with or without Hashimoto's thyroiditis.
    Zhu Y, Zheng K, Zhang H, Chen L, Xue J, Ding M, Wu K, Wang Z, Kong L, Chen X.
    Tumour Biol; 2016 Jun 23; 37(6):8037-45. PubMed ID: 26711787
    [Abstract] [Full Text] [Related]

  • 11. PD-L1, PDK-1 and p-Akt are correlated in patients with papillary thyroid carcinoma.
    Wang H, Zhang Z, Yan Z, Ma S.
    Adv Clin Exp Med; 2020 Jul 23; 29(7):785-792. PubMed ID: 32750756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda M, Kameyama K, Takami H, Ito K.
    World J Surg; 2014 Jan 23; 38(1):68-79. PubMed ID: 24081532
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
    Cai YF, Wang QX, Ni CJ, Guo GL, Li Q, Wang OC, Wu L, Du HY, You J, Zhang XH.
    Medicine (Baltimore); 2015 Nov 23; 94(44):e1881. PubMed ID: 26554782
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Predictive relevance of programmed cell death protein 1 and tumor-infiltrating lymphocyte expression in papillary thyroid cancer.
    Aghajani MJ, Yang T, McCafferty CE, Graham S, Wu X, Niles N.
    Surgery; 2018 Jan 23; 163(1):130-136. PubMed ID: 29128181
    [Abstract] [Full Text] [Related]

  • 18. Multifocality, but not bilaterality, is a predictor of disease recurrence/persistence of papillary thyroid carcinoma.
    Kim HJ, Sohn SY, Jang HW, Kim SW, Chung JH.
    World J Surg; 2013 Feb 23; 37(2):376-84. PubMed ID: 23135422
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological features of recurrent papillary thyroid cancer.
    Zhu J, Wang X, Zhang X, Li P, Hou H.
    Diagn Pathol; 2015 Jul 14; 10():96. PubMed ID: 26168921
    [Abstract] [Full Text] [Related]

  • 20. Number of tumor foci predicts prognosis in papillary thyroid cancer.
    Qu N, Zhang L, Ji QH, Zhu YX, Wang ZY, Shen Q, Wang Y, Li DS.
    BMC Cancer; 2014 Dec 04; 14():914. PubMed ID: 25471041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.